DrugDashboards

sinus 12 hour

Pseudoephedrine HCl · PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 · Tablet, Film Coated, Extended Release · Oral · L. Perrigo Company

NDC 00113-2017-60 · 20 BLISTER PACK in 1 CARTON / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble. The price is up 11% over the past year, to $0.2805 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4Feb 2020Sep 2026$0.2805
58 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$8.42
#90 count
$25.25

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for pseudoephedrine hcl (oral solid) in the next 90 days

price up 26% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA075153
TE code
Approval date
Feb 26, 1999
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Pseudoephedrine HCl (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
American Sales CompanyPSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Cardinal Health 110, LLC. dba LeaderPSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
L. Perrigo CompanyPSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsPSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Padagis Israel Pharmaceuticals LtdPSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Rite Aid CorporationPSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "sinus 12 hour — NDC 00113-2017-60," retrieved September 3, 2026, https://drugdashboards.com/drug/00113201760.

Free to cite with attribution — see how the data is put together.